Menopausal Hormone Therapy Usage Rates Decline from 2007 to 2023

Tuesday, 10 September 2024, 23:30

Menopausal hormone therapy (HT) usage rates have declined significantly from 2007 to 2023, indicating a tendency towards lower engagement with hormonal treatments. This trend was highlighted in a recent study presented at The Menopause Society annual meeting. As a result, healthcare practitioners are urged to reevaluate the counseling provided regarding HT options.
Physiciansweekly
Menopausal Hormone Therapy Usage Rates Decline from 2007 to 2023

Overview of Hormonal Treatment Usage

Menopausal hormone therapy (HT) has experienced a significant decline in usage rates from 2007 to 2023. The latest findings were discussed at a conference held by The Menopause Society from September 10 to 14. Health practitioners reported a notable drop in women opting for HT for symptom relief during menopause. The data indicate that awareness and education around the benefits and risks of HT need enhancement.

Key Findings

  • Study Highlight: Menopausal hormone therapy rates are at an all-time low.
  • Potential Causes: Shift in public perception regarding hormone therapy risks.
  • Recommendations: Increased patient education on treatment options.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe